LogicBio Therapeutics, Inc. Clinical Trials
Studies registered on ClinicalTrials.gov (U.S. National Library of Medicine) with the company as lead sponsor or collaborator, newest start first. Values are as registered.
- 2021-05-29: Study NCT04581785; Company role Lead sponsor; Phase Phase 1, Phase 2; Status Terminated.
| Start date | Study | Company role | Phase | Status | Conditions | Enrollment | Completion date |
|---|---|---|---|---|---|---|---|
| 2021-05-29 | NCT04581785 Gene Therapy With hLB-001 in Pediatric Patients With Severe Methylmalonic Acidemia | Lead sponsor | Phase 1, Phase 2 | Terminated Results posted | Methylmalonic Acidemia | 4 | 2023-01-10 |